Research to improve the quality of antivenom and the treatment system using antivenom (AMED Ato Group)

For medical professionals For medical

Co-researcher Joe Chiba, Professor Emeritus of Tokyo University of Science, explains serum therapy for novel coronavirus infections in Nikkei Biotech.

Nikkei Biotech Article

Findings Reveal a Boost to Vaccine Development for New Coronas 


To evaluate “inexpensive, quick-start” classical therapy (serum therapy) for new coronas. 


Can Immune Memory of “Past Colds” Save the World from New Coronas? 


Organoids Elucidate Mechanism of Multi-Organ Injury Caused by New Corona 


Guest Researcher, National Institute of Infectious Diseases

Joe Chiba